Company News

  • 19 June 2018

    Avedro starts enrolment in ACP-KXL-308 trial

    Avedro has started patient enrolment in the ACP-KXL-308 trial, a pivotal Phase lll clinical study to examine the safety and efficacy of an epithelium-on (epi-on) corneal collagen cross-linking (CXL) procedure...

  • 15 June 2018

    Prana receives approval for Phase l trial of PBT434

    Prana Biotechnology has received approval from the ethics committee to begin a Phase I clinical trial to investigate the safety, tolerability and pharmacokinetics of PBT434 for the treatment of Parkinsonian...